AnserBio logo
Healthcare & Life Sciences

AnserBio

AnserBio is a Healthcare & Life Sciences startup based in Israel, most recent round Series A, 1 tracked investor.

unknownseries-a
series-a
Stage
2020
Founded
1
Investors

About AnserBio

AnserBio is a startup founded in 2020 based in Israel. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

AnserBio develops an oncology therapeutic delivery platform using exosomes to deliver healthy p53 protein for restoring tumor suppression in cancers with TP53 gene mutations.

Explore AnserBio's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Israel